Mercado mundial de inhibidores de corticosteroides suprarrenales: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de inhibidores de corticosteroides suprarrenales

Se prevé que el mercado de inhibidores de corticosteroides suprarrenales experimente un enorme crecimiento durante el período de pronóstico. El aumento en la incidencia del cáncer de próstata está impulsando el mercado de medicamentos inhibidores de corticosteroides suprarrenales. Según los registros del Fondo Mundial para la Investigación del Cáncer, en 2012 se detectaron más de 1,1 millones de casos de cáncer de próstata, lo que representa alrededor del 15% de los casos en hombres y casi el 8% del total de casos nuevos. También se debe al aumento de la incidencia del cáncer de mama y a la alta tasa de diagnósticos.

Data Bridge Market Research analiza la tasa de crecimiento del mercado de inhibidores de corticosteroides suprarrenales en el período de pronóstico 2023-2030. La CAGR esperada del mercado de inhibidores de corticosteroides suprarrenales tiende a rondar el 12,5% en el período de pronóstico mencionado. El mercado se valoró en USD 2.25 mil millones en 2022 y crecería hasta USD 5.77 mil millones para 2030. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de inhibidores de corticosteroides suprarrenales

Definición de mercado

Adrenal corticosteroid inhibitors are the type which are extensively used for the treatment of cushing's syndrome and some types of solid tumors such as breast cancer. It employs their effect by hindering endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the enzymes responsible for steroid synthesis pathway. These drugs are also used when the adrenal cortex is overactive and not leading towards cancer.

Adrenal Corticosteroid Inhibitors Market Dynamics

Drivers

• Increasing Incidence of Breast Cancer

The increasing cases of breast cancer globally in developed and under-developed countries boosts the market. According to WHO, 58% of deaths caused by breast cancer mostly occur in under-developed or developing countries globally. In the year 2020, there were around 2.3 million women diagnosed with breast cancer and 685 000 deaths worldwide. As of the end of 2020, there were nearly 7.8 million women alive who were diagnosed with breast cancer in the past 5 years. Thus, this increasing prevalence boosts the demand for these inhibitors.

• Increasing Demand for Oral Drugs

The increasing demand for oral drugs is anticipated to boost the market growth. The segment is projected to increase the global market as most of the products are available in capsule and tablet form and it is a very convenient route of administration.

Opportunities

• Increasing Incidence of Prostate Cancer

According to World Cancer Research Fund International, around 1.1 million cases of prostate cancer were observed in 2012 which resulted for around 15% cases in men. In addition to this, growing prevalence of Cushing’s syndrome boosts the demand for these drugs. The estimated numbers of new cancer cases and deaths in 2022. In the year 2022, there will be approximately 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. Thus, this increasing prevalence boosts the market growth.

• Growing Demand for Retail Pharmacies

Increase in the number of cortical necrosis therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global adrenal corticosteroid market during the forecast period.

• High Cost of Treatment

The increasing expenditure related with medications hamper the market growth. These inhibitors cost high and people in underdeveloped countries, result in the under treatment of several patients. This hampers the market growth.

This adrenal corticosteroid inhibitors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenal corticosteroid inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Adrenal Corticosteroid Inhibitors Market         

COVID-19 has left a major impact that has disturbed every business, and its long-term consequences are anticipated to influence industry growth during the forecast period 2023-2030. Shift of healthcare infrastructure towards managing COVID-19 has led to drug approval cancellations and delays in clinical trials.

However, in the post-pandemic era, the biotechnology and pharmaceutical industries are anticipated to witness a huge growth in the future, because of the demand for vaccine and other treatment drugs for COVID-19. Therefore, the market is seeing a rise in the current era.

Global Adrenal Corticosteroid Inhibitors Market Scope

The adrenal corticosteroid inhibitors market is segmented on the basis of drug, type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Breast Cancer
• Prostate Cancer
• Cushing's Syndrome
• Others

Drug

• Osilodrostat
• Metyrapone
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Adrenal Corticosteroid Inhibitors Market Regional Analysis/Insights

The adrenal corticosteroid inhibitors market is analyzed and market size insights and trends are provided by drug, type, distribution channel and end-user as referenced above.

The major countries covered in the adrenal corticosteroid inhibitors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

América del Norte ha sido testigo de un crecimiento positivo para el mercado de inhibidores de corticosteroides suprarrenales durante el período previsto debido a la alta demanda de tratamientos específicos para enfermedades y al mayor nivel de concienciación de los pacientes, así como a la alta prevalencia del cáncer de mama y la enfermedad de Cushing.

Asia-Pacífico domina el mercado debido al aumento del número de fabricantes de genéricos en esta región, así como al creciente ingreso disponible.

La sección de países del informe también proporciona factores de impacto individuales en el mercado y cambios en la regulación del mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Además, se consideran la presencia y disponibilidad de marcas globales y los desafíos que enfrentan debido a la gran o escasa competencia de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales, al tiempo que se proporciona un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado global de inhibidores de corticosteroides suprarrenales

El panorama competitivo del mercado de inhibidores de corticosteroides suprarrenales proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de inhibidores de corticosteroides suprarrenales.

Los actores clave que operan en el mercado de inhibidores de corticosteroides suprarrenales incluyen:

• ChemGenix (India)
• Ciba AG (Suiza)
• Crinetics Pharmaceuticals, Inc. (Estados Unidos)
• HRA Pharma (Estados Unidos)
• Merck KGaA (Alemania)
• Novartis AG (Estados Unidos)
• Recordati SPA (Italia)
• Tocris Bioscience (Reino Unido)

SKU-53689